Clinical symptoms of the effectiveness of combination therapy for onychomycosis of dermatomycete etiology

Abstract

Onychomycosis is widespread all over the world. The choice of treatment tactics continues to be a difficult task for dermatologists. The use of combination therapy showed high clinical and mycological results of treatment, and also reduced the risk of relapses after discontinuation of therapy. Evaluation of the effectiveness of this therapy is based on knowledge of the reverse development of clinical symptoms.

Keywords

onychomycosis / dermatomycetes / combined therapy / symptoms of onychomycosis

References

[1] Kaur R, Kashyap B, Bhalla P. Onychomycosis – epidemiology, diagnosis and management. Indian J Med Microbiol. 2008;26(2):108-16. doi: 10.4103/0255-0857.40522.

[2] Kaur R., Kashyap B., Bhalla P. Onychomycosis – epide- miology, diagnosis and management. Indian J Med Microbiol. 2008;26(2):108-16. doi: 10.4103/0255-0857.40522.

[3] Bodman MA, Krishnamurthy K. Onychomycosis. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan. 2020 Aug 8. PMID: 28722883.

[4] Bodman M.A., Krishnamurthy K. Onychomycosis. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan. 2020 Aug 8. PMID: 28722883.

[5] Kasikhina EI, Yakovlev AB. Onychomycosis. Attending Physician. Russian Journal. 2012;(5):49-53. (in Russian)

[6] Касихина Е.И., Яковлев А.Б. Онихомикозы // Лечащий врач. 2012;(5):49-53.

[7] Saliy ЕА. Onychomycosis. Epidemiology, etiopathogenesis, treatment Dermatovenerology. Cosmetology. Sexual Pathology. Ukrainian Journal. 2011;(1-4):110-4. (in Russian)

[8] Салий Е.А. Онихомиозы (эпидемиология, этиопатогенез, лечение). Дерматовенерология. Косметология. Сексопатология. 2011;(1-4):110-4.

[9] Sergeev AYu. Update views on pathogenesis of onychomycosis. International Journal of Immunopathology, Allergology, Infectology. Russian Journal. 2000;(1):100-9. (in Russian)

[10] Сергеев А.Ю. Современные представления о патогенезе онихомикоза // Иммунопатология, Аллергология, Инфектология. 2000;(1):100-9.

[11] Sergeev YuV, Mokina EV, Sergeev AYu, Burtseva GN, Baranova MO, Savchenko NV, Sergeev VYu. Local and combined therapy of onychomycosis. Moscow: National Academy of Mycology; 2015. (in Russian)

[12] Сергеев Ю.В., Мокина Е.В., Сергеев А.Ю., Бурцева Г.Н., Баранова М.О., Савченко Н.В., Сергеев В.Ю. Местная и комбинированная терапия онихомикозов. М.: Национальная академия микологии; 2015.

[13] Rashid A, Scott E, Richardson MD. Early events in the invasion of the human nail plate by Trichophyton mentagrophytes. Br J Dermatol. 1995;133(6):932-40.

[14] Rashid A., Scott E., Richardson M.D. Early events in the invasion of the human nail plate by Trichophyton mentagrophytes. Br J Dermatol. 1995;133(6):932-40.

[15] Gerasimchuk EV. the role of Modern topical treatment to skin and nail fungal infections in older adults. Clinical gerontology. Russian Journal. 2016;(7-8):63-5. (in Russian)

[16] Герасимчук Е.В. Роль современных наружных противогрибковых препаратов в лечении микотической инфекции кожи стоп и ногтей у геронтологических больных // Клиническая геронтология. 2016;(7-8):64-6.

[17] Potekaev NN, Molochkov VA, Shakhova LM, Shishkova MV. Combined therapy of onychomycosis: approaches and prospects. Advances in Medical Mycology. Russian Journal. 2004;(4):307-8. (in Russian)

[18] Потекаев Н.Н., Молочков В.А., Шнахова Л.М., Шишкова М.В. Комбинированная терапия онихомикоза: подходы и перспективы // Успехи медицинской микологии. 2004;(4):307-8.

[19] Ryder NS. Terbinafine: mode of action and properties of the squalene epoxidase inhibition. Br J Dermatol. 1992;126(Suppl.39):2-7.

[20] Ryder N.S. Terbinafine: mode of action and properties of the squalene epoxidase inhibition. Br J Dermatol. 1992;126(Suppl.39):2-7.

[21] Sigurgeirsson B, Olafsson JH, Steinsson JB, Pau C, Billstein S, Evans GV. Long-term effectiveness of treatment with terbinafine vs itraconazole in onychomycosis: a 5-year blinded prospective follow-up study. Arch Dermatol. 2002;138(3):353-7.

[22] Sigurgeirsson B., Olafsson J.H., Steinsson J.B., Pau C., Billstein S., Evans G.V. Long-term effectiveness of treatment with terbinafine vs itraconazole in onychomycosis: a 5-year blinded prospective follow-up study. Arch Dermatol. 2002;138(3):353-7.

[23] Baran R, Hay RJ, Garduno JI. Review of antifungal therapy and the severity index for assessing onychomycosis: part I. J Dermatolog Treat. 2008;19(2):72-81.

[24] Baran R., Hay R.J., Garduno J.I. Review of antifungal therapy and the severity index for assessing onychomycosis: part I. J Dermatolog Treat. 2008;19(2):72-81.

[25] Grover C, Khurana A. An update on treatment of onychomycosis. Mycoses. 2012;55(6):541-51. doi: 10.1111/j.1439-0507.2012.02199.x.

[26] Grover C., Khurana A. An update on treatment of onycho- mycosis. Mycoses. 2012;55(6):541-51. doi: 10.1111/j.1439-0507.2012.02199.x.

[27] Bhatta AK, Keyal U, Wang X, Gellen E. A review of the mechanism of action of lasers and photodynamic therapy for onychomycosis. Lasers Med Sci. 2017;32(2):469-74.

[28] Bhatta A.K., Keyal U., Wang X., Gellen E. A review of the mechanism of action of lasers and photodynamic therapy for onychomycosis. Lasers Med Sci. 2017;32(2):469-74.

[29] Potekaev NN, Kruglova LS. Lasers in Dermatology and Cosmetology. Moscow: Alkor Publishers; 2018. (in Russian)

[30] Потекаев Н.Н., Круглова Л.С. Лазеры в дерматологии и косметологии. М.: Алькор Паблишерс; 2018.

[31] Kawa N, Lee KC, Anderson RR, Garibyan L. Onychomycosis: A review of new and emerging topical and device-based treatments. J Clin Aesthet Dermatol. 2019;12(10):29-34.

[32] Kawa N., Lee K.C., Anderson R.R., Garibyan L. Onychomycosis: A review of new and emerging topical and device-based treatments. J Clin Aesthet Dermatol. 2019;12(10):29-34.

[33] Sergeev YuV, Sergeev VYu. What is a combination theatment and how it may be used in onychomycosis. Herald of Venerology and Dermatology. Russian Journal. 2011;(5):125-30. (in Russian)

[34] Сергеев Ю.В., Сергеев В.Ю. Что такое комбинированная терапия и как ее можно использовать при онихомикозах // Вестник дерматологии и венерологии. 2011;(5):125-30.

[35] Lecha M, Alsina M, Torres Rodriguez JM, de Erenchun FR, Mirada A, Rossi AB. An open-label, multicenter study of the combination of amorolfine nail lacquer and oral itraconazole compared with oral itraconazole alone in the treatment of severe toenail onychomycosis. Curr Ther Res. 2002;63(6):366-79.

[36] Lecha M., Alsina M., Torres Rodriguez J.M., de Erenchun F.R., Mirada A., Rossi A.B. An open-label, multicenter study of the combination of amorolfine nail lacquer and oral itraconazole compared with oral itraconazole alone in the treatment of severe toenail onychomycosis. Curr Ther Res. 2002;63(6):366-79.

[37] Leelavathi M, Noorlaily MN. Onychomycosis nailed. Malays Fam Physician. 2014;9(1):2-7.

[38] Leelavathi M., Noorlaily M.N. Onychomycosis nailed. Malays Fam Physician. 2014;9(1):2-7.

[39] Rukavishnikova VM. Mycosis of the feet. Moscow: AlexCom; 2003. (in Russian)

[40] Рукавишникова В.М. Микозы стоп. М.: ЭликсКом; 2003.

RIGHTS & PERMISSIONS

Eco-Vector